Assembly Biosciences (ASMB) Current Deferred Revenue (2017 - 2026)
Assembly Biosciences' Current Deferred Revenue came in at $16.3 million for Q2 2026, down 60.2% from $40.92 million a year earlier and down 43.9% from the prior quarter.
Powered by 
Analysis
Assembly Biosciences (ASMB) Current Deferred Revenue (2017 - 2026) Analysis & Trends
At the end of FY2025, Assembly Biosciences' Current Deferred Revenue was $36.9 million, down 1.9% from FY2024.
- Going back by year, Current Deferred Revenue was $37.62 million in FY2024 (+21.7%) and $30.92 million in FY2023.
- The Q2 2026 figure represents the lowest quarterly Current Deferred Revenue since Q1 2020.
- Year-over-year, Current Deferred Revenue has declined for three consecutive quarters, with growth averaging 1.3% over the last seven quarters.
- Business Quant data shows ASMB's Current Deferred Revenue at $29.08 million (Q1 2026), $36.9 million (Q4 2025) and $42.36 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Assembly Biosciences | 386.12 Mn | -641.50 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.30 Mn |
| Mar 31, 2026 | 29.08 Mn |
| Dec 31, 2025 | 36.90 Mn |
| Sep 30, 2025 | 42.36 Mn |
| Jun 30, 2025 | 40.92 Mn |
| Mar 31, 2025 | 40.82 Mn |
| Dec 31, 2024 | 37.62 Mn |
| Sep 30, 2024 | 32.62 Mn |
| Jun 30, 2024 | 33.06 Mn |
| Mar 31, 2024 | 32.77 Mn |
| Dec 31, 2023 | 30.92 Mn |
| Mar 31, 2020 | 6.72 Mn |
| Dec 31, 2019 | 6.41 Mn |
| Sep 30, 2019 | 6.15 Mn |
| Jun 30, 2019 | 6.08 Mn |
| Mar 31, 2019 | 9.93 Mn |
| Dec 31, 2018 | 5.10 Mn |
| Sep 30, 2018 | 5.11 Mn |
| Jun 30, 2018 | 5.51 Mn |
| Mar 31, 2018 | 5.16 Mn |
API Access
Assembly Biosciences Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ASMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "ASMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ASMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();